The expression of gut peptides receptor on pancreatic endocrine tumors

( views:, downloads: )
Biemond I()
Verspaget HW()
Lamers CBHW()
Journal Title:
Volume 2, Issue 01, 2002
Key Word:


  • [1]Oberg K. Clinical syndrome, diagnosis and therapy of Glendoc rine tumours and MEN-1. In: SingerMV, et al editors. Gastro intestinal tract and endocrine system. Dordrecht: Kluwer Academic Publishers, 1995:406-416
  • [2]Tang C, Biemond I, Lamers CBHW. Localization and quantific ation of cholecystokinin receptors in rat brain with storage phosphor autoradiography. BioTechniques, 1995,18: 886-889
  • [3]Jansen JBMJ, Lamers CBHW. Low binding of Bolton Hunter labelled cholecystokinin-33 to carboxyl terminal CCK-antibodi es. J Immunol Methods, 1982,51:223-230
  • [4]Ensinck JW, Laschansky EC, Vogel RE, et al. Circulating pro somatostatin-derived peptides differential responses to food ingestion. J ClinInvest 1989,83:1580-1589
  • [5]Tang C, Biemond 1, Offevhaus GJA, et al. Expression of recep tors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas, Br J Cancer, 1997,75:1467-1473
  • [6]Johnston RF, Pickett SC, Barker D. Autoradiography using st orage phosphor technology. Electrophoresis, 1990,11: 355-360
  • [7]Jensen RT, Gardner JD. Gastrinoma. In: Go VLW, et al edito rs. The pancreas: Biology, Pathobiology, and Disease. New York: Raven Press, 1993:931-978
  • [8]Virgolini I, Raderer M, Kurtaran A, et al. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumours. N Engl J Med, 1994, 331:1116-1121
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615